What are the criteria for choosing and switching between similar biological treatment options in patients with atopic and non-atopic severe eosinophilic asthma?

• To determine the criteria for starting on and switching from specific biologic treatments based on the demographic and clinical characteristics as well as prospective outcomes in atopic/non atopic severe eosinophilic asthmatics.

Prof. George C. Christoff (Bulgaria)

ENCePP:
ADEPT: